Close

Articles Posted in Pharmaceutical Drugs

Updated:

Should Companies Be Required to Disclosure Expected Litigation Obligations in Product Cases?

The Wall Street Journal has an editorial with an anti products liability lawyer spin. No surprise. But what is surprising is that I agree with it. Considering Enron and other business collapses that left stockholders holding the bag with no actual picture of the company’s financial condition, the Financial Accounting…

Updated:

Riegel v. Medtronic: Congress to the Rescue?

Since the Supreme Court’s disaster in Riegel v. Medtronic, I have been hoping and expecting Congress would step in to fix the Supreme Court’s ruling, because it was clear from the amicus briefs submitted in Riegel, from history, and from common sense, that Congress did not intend to prevent medical…

Updated:

Riegel v. Medtronic: New England Journal of Medicine Editorial

There is an editorial in this month’s New England Journal of Medicine on Riegel v. Medtronic, the preemption case that the Supreme Court shall soon side that has pharmaceutical and medical device companies sitting on the edge of their seats. Quick background: A man suffered injuries when a balloon catheter…

Updated:

Riegel v. Medtronic: The FDA Preemption Super Bowl

Today, the Supreme Court will hear arguments in Riegel v. Medtronic. The issue is whether the Food, Drug, and Cosmetic Act forecloses state law personal injury lawsuits for injuries from the design, manufacture, and labeling of a Medtronic medical device that the Food and Drug Administration initially granted a pre-market…

Contact Us